Xen Biofluidx Inc is a research and assay development company providing services to the life science and diagnostics community and helping to transform biomarker discoveries into reliable tools for the diagnosis and prevention of disease. Xen Biofluidx primarily focus their efforts on assay development, surface chemistry, and antibody engineering. The firm is well versed in the practice of stabilizing biological reagents through formulation and lyophilization, often required for assay integration. The company holds several patent pending technologies that are unique to the point-of-care detection of biomolecules present in blood and other biological fluids at very low levels.
